What Happened?
Chandler, -based Insys Resigned Mark Nance as Chief Legal Officer and General Counsel
About the Company
Insys Therapeutics is a commercial-stage specialty pharmaceutical company that develops and commercializes innovative supportive care products. We have two marketed products, Subsys and Dronabinol SG Capsule, which leverage our sublingual spray drug delivery technology and dronabinol formulation and manufacturing capabilities, respectively. In March 2012, we launched Subsys, our proprietary sublingual fentanyl spray for breakthrough cancer pain, or BTCP, in opioid-tolerant patients. Our focus is on the discovery, development and commercialization of innovative products to address chemotherapy-induced nausea and vomiting (CINV), pain management and other central nervous system disorders.
About the Person
Mark Nance is Chief Legal Officer and General Counsel at Insys. Previously, Mark held various senior legal leadership roles in the industry.
Info Source
News
Short Profile